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Abstract
Aims: Despite increased recognition as a chronic disease, obesity remains greatly
underdiagnosed and undertreated. We aimed to identify international perceptions,
attitudes, behaviours and barriers to effective obesity care in people with obesity
(PwO) and healthcare professionals (HCPs).
Materials and methods: An online survey was conducted in 11 countries. Participants
were adults with obesity and HCPs who were primarily concerned with direct
patient care.
Results: A total of 14 502 PwO and 2785 HCPs completed the survey. Most PwO
(68%) and HCPs (88%) agreed that obesity is a disease. However, 81% of PwO
assumed complete responsibility for their own weight loss and only 44% of HCPs
agreed that genetics were a barrier. There was a median of three (mean, six) years
between the time PwO began struggling with excess weight or obesity and when
they first discussed their weight with an HCP. Many PwO were concerned about the
impact of excess weight on health (46%) and were motivated to lose weight (48%).
Most PwO (68%) would like their HCP to initiate a conversation about weight and
only 3% were offended by such a conversation. Among HCPs, belief that patients
have little interest in or motivation for weight management may constitute a barrier
for weight management conversations. When discussed, HCPs typically rec-
ommended lifestyle changes; however, more referrals and follow-up appointments
are required.
Conclusions: Our international dataset reveals a need to increase understanding of
obesity and improve education concerning its physiological basis and clinical manage-
ment. Realization that PwO are motivated to lose weight offers an opportunity for
HCPs to initiate earlier weight management conversations.
Received: 20 February 2019 Revised: 3 April 2019 Accepted: 16 April 2019
DOI: 10.1111/dom.13752
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
© 2019 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Diabetes Obes Metab. 2019;1–11. wileyonlinelibrary.com/journal/dom 1
16CIBER Fisiopatología de la Obesidad y
Nutrición, Instituto de Salud Carlos III,
Majadahonda, Spain
17Department of Systems Medicine, University
of Rome Tor Vergata, Rome, Italy
18Clínica de Obesidad y Trastornos de la
Conducta Alimentaria, Instituto Nacional de
Ciencias Médicas y Nutrición Salvador
Zubirán, Ciudad de México, Mexico
19Department of Psychological Sciences,
University of Liverpool, Liverpool, UK
Correspondence
Ian D. Caterson FRACP, Boden Institute,
Charles Perkins Centre D17, University of
Sydney, NSW 2006, Australia.
Email: ian.caterson@sydney.edu.au
Funding information
This study was sponsored by Novo Nordisk.
K E YWORD S
ACTION-IO, attitudes, barriers, international, obesity, perceptions
1 | INTRODUCTION
Obesity is a serious, chronic, relapsing disease with a high prevalence
and a substantial unmet medical need.1,2 This complex disease is
influenced by multiple factors including genetics, physiological factors,
psychological issues and environmental variables, both physical and
social, and it affects individuals of all ages and regions.2-4 Obesity is
associated with multiple complications and an increased risk of dis-
ability and mortality.5-7 Individuals living with obesity experience
stigma, discrimination and a negative impact on both mental and
health-related quality of life.4,7,8
Treatment guidelines for people with obesity (PwO) typically rec-
ommend lifestyle interventions with addition of pharmacotherapy if
response to dietary, physical activity and behavioural changes alone is
insufficient to reach or maintain the recommended goal of 5%–10%
loss in body weight.9-15 Bariatric surgery should be considered for
severe cases (body mass index [BMI] ≥40 kg/m2 or ≥35 kg/m2 with
obesity-related complications) and may be considered for PwO
(BMI ≥30 kg/m2) with poorly controlled type 2 diabetes.9-15 Despite
the availability of these guidelines, in practice, PwO experience vari-
able care.16-18 The Awareness, Care, and Treatment In Obesity maN-
agement (ACTION) survey study conducted in the USA identified low
rates of obesity diagnosis and management.19 In another survey of
1506 healthcare professionals (HCPs) in the USA, most (84%) demon-
strated limited knowledge of obesity treatment guidelines.20 An inter-
national study of 335 HCPs suggested a disconnect between HCPs'
confidence in their ability to manage patients with excess weight and
their effectiveness in achieving weight loss goals.21
To improve the quality of, and access to, obesity care globally, a
better understanding of the disease and the way those with obesity
are currently, and should be, managed is required. The objective of
the ACTION International Observation (ACTION-IO) study was to
identify the perceptions, attitudes and behaviours of PwO and HCPs
and to assess the potential barriers to effective obesity care on an
international scale. Here we report the primary results from the
ACTION-IO study which, to our knowledge, is the largest international
survey of PwO and HCPs to date.
2 | METHODS
2.1 | Study design and participants
The ACTION-IO study was a cross-sectional, non-interventional,
descriptive study that collected data via an online survey conducted
by a third-party vendor (KJT Group, Honeoye Falls, New York), utiliz-
ing existing databases/panels in 11 countries across different world
regions (Australia, Chile, Israel, Italy, Japan, Mexico, Saudi Arabia,
South Korea, Spain, the UAE and the UK) between 4 June 2018 and
15 October 2018. It was intended to also include Brazil, but it was not
possible to obtain local ethics committee approval within the required
timelines.
Eligible PwO were 18 years or older and were residents of a par-
ticipating country, with a current BMI, based on self-reported height
and weight, of at least 30 kg/m2 or at least 25 kg/m2 in Japan and
South Korea, as per country-specific definitions of obesity.22 PwO
were excluded if they declined to provide information concerning
income, with the exception of Mexico as required by the local ethics
committee, or concerning race/ethnicity, in Australia and the UAE
only, if they were pregnant, if they participated in intense fitness or
body building programmes or if they had experienced significant, uni-
ntentional weight loss during the past 6 months. Eligible HCPs were
medical practitioners in a participating country, who had been in prac-
tice for 2 years or more, with at least 70% of their time involved in
direct patient care and who had seen 100 or more patients during the
past month, at least ten of whom had a BMI of at least 30 kg/m2, or
25 kg/m2 in Japan and South Korea. HCPs specializing in general,
plastic or bariatric surgery were excluded.
All respondents provided electronic informed consent prior to ini-
tiation of the screening questions and survey. A local ethics com-
mittee/independent review board approved the questionnaires in
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Australia, Israel, Mexico, Saudi Arabia, South Korea, Spain, the UAE
and the UK, where such approval was required. For Chile, Italy and
Japan, ethical approval was determined to be non-essential for a study
of this nature based on regulatory standards and precedent. The study
complied with all laws and regulations regarding management of per-
sonal information as required by the participant's country of residence
and the European General Data Protection Regulation. The study was
conducted in accordance with the Guidelines for Good Phar-
macoepidemiology Practices23 and is registered with ClinicalTrials.gov,
number NCT03584191.
2.2 | Survey development and pre-testing
Two questionnaires, one for PwO and one for HCPs (Appendix S1,
pages 28–139), were developed by an international steering commit-
tee of obesity experts, representing primary care, medical specialities
and psychology, from the participating countries, in addition to three
medical doctors employed by the sponsor, Novo Nordisk. The ques-
tionnaires were based on those used in the ACTION US19 and
ACTION Canada studies,24 with minor modification or removal of
some original questions to reduce survey length, increase data quality
and ensure that questions were relevant to the study objectives. KJT
Group conducted 60-minute web-assisted pre-tests with four PwO
and four HCPs in each country; participants took the survey online
while speaking with a moderator by telephone, or in-person in Japan,
Saudi Arabia, South Korea, and the UAE. This was to assess clarity,
face validity and relevance of the questions. Surveys were designed
to facilitate comparisons within and across respondent types.
2.3 | Procedures
KJT Group oversaw all aspects of data collection and reporting. Data
were collected through an online survey programmed by KJT Group,
using Decipher Survey Software (FocusVision Worldwide Inc., Stam-
ford, Connecticut). To reduce PwO sampling bias and ensure that the
group was largely representative of the general population, the out-
bound sample was sent according to pre-determined demographic tar-
gets based on gender, age, income, race/ethnicity, in select countries,
and region. Targets were established based on data from the 2011
International Standard Classification of Education and the US Census
Bureau, International Data Base and other public data. Prior to partici-
pation, respondents were blinded to the specific study goals, being
informed that the purpose was “to determine treatment experiences
of patients with a specific condition”. All individuals could access the
first part of the survey, and an initial set of screening questions deter-
mined eligibility based on the demographic targets; subsequently, only
respondents who had obesity, as determined from their self-reported
height and weight, and who met the other eligibility requirements as
detailed in the Study design and participants section, proceeded into
the full survey. Demographic targets were monitored throughout data
collection to ensure population representativeness.
Respondents were compensated for their time and were recruited,
for the most part, via online panel companies to whom they had given
permission to be contacted for research purposes (Appendix S1,
page 2). Respondents were recruited through email where possible,
with telephone and in-person recruitment also used for PwO in Saudi
Arabia and the UAE and for HCPs in Chile, Japan, Israel, Mexico, Saudi
Arabia, South Korea and the UAE. Respondents completed the survey
in the native language of their country. In-person administration of
the online survey was permitted for PwO in Saudi Arabia and the UAE
and for HCPs in Chile, Japan, Israel, Mexico, Saudi Arabia, South
Korea and the UAE (Appendix S1, page 2). All respondents could sus-
pend taking the survey at any time and for any reason at any part of
the survey. Participants were allowed to complete the survey only
once, as assessed by prior online consent and digital fingerprinting
(Appendix S1, page 2). To avoid bias, questionnaire items were care-
fully phrased and presented in the same order for each respondent
and items in a list were displayed alphabetically, categorically, chrono-
logically or randomly, as relevant for each response set.
2.4 | Outcomes
Outcomes were measured by multiple item selection (weight loss
motivators, effective weight loss methods, types of weight manage-
ment goals, most helpful information for patients concerning weight
loss, responsibility for improving health of PwO, most helpful support
for weight loss and ways information concerning weight loss manage-
ment is received), numeric response (proportion of PwO who made a
serious weight loss effort), single item selection (response to weight
loss discussions), end-anchored 5-point Likert agreement scales (atti-
tudes toward obesity, attitudes toward prescription weight loss medi-
cation and surgery, weight loss barriers, obesity and weight
management, and the degree to which healthcare and society are
meeting the needs of PwO), fully anchored 5-point Likert scales
(effectiveness of guidelines for treating obesity) and by ranking (top
factors for improving weight loss outcomes). Some of these outcomes
will be published separately.
2.5 | Analysis
The target sample size, based on 12 participating countries, was
19 700 completed surveys, comprising 16 500 PwO (750–2000 per
country) and 3200 HCPs (200–300 per country; 1600 primary care
professionals [PCPs] plus 1600 non-PCP specialists), to balance statis-
tical power, recruitment feasibility and cost.
Analysis of de-identified data was conducted by KJT Group using
SPSS (IBM, version 23.0), Stata (StataCorp LLC, version IC 14.2) and
Excel (Microsoft, version 2016). Data were summarized using univari-
ate descriptive statistics (means, medians, frequencies) and tests of
differences (chi square, t-tests) within PwO or HCP respondent types
were performed. Statistical significance was set at P < 0.05, using
2-tailed tests. Adjustment for multiple testing was not undertaken as
this research was exploratory and descriptive in nature. Only data
from those who completed the survey were included in the analyses.
The final PwO sample, including those failing to qualify for the
survey, was weighted to representative demographic targets within
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TABLE 1 Sample demographics and characteristics
PwO (n = 14 502) HCPs (n = 2785)
Age, years 43 (18–88) 48 (26–74)
Gender
Male 7438 (51%) 1958 (70%)
Female 7050 (49%) 827 (30%)
Other 14 (<1%) 0
Country
Australia 1000 (7%) 200 (7%)
Chile 1000 (7%) 200 (7%)
Israel 750 (5%) 169 (6%)
Italy 1501 (10%) 302 (11%)
Japan 2001 (14%) 302 (11%)
Mexico 2000 (14%) 400 (14%)
Saudi Arabia 1000 (7%) 200 (7%)
South Korea 1500 (10%) 200 (7%)
Spain 1500 (10%) 306 (11%)
UAE 750 (5%) 200 (7%)
UK 1500 (10%) 306 (11%)
BMI classification for Australia, Chile, Israel, Italy, Mexico, Saudi Arabia, Spain, UAE and UKa
Respondents 11 001 (100%) 1778 (78%)
Underweight or healthy range
(<25 kg/m2)
– 971 (55%)
Overweight (25–29.9 kg/m2) – 668 (38%)
Obesity Class I (30–34.9 kg/m2) 6930 (63%) 103 (6%)
Obesity Class II (35–39.9 kg/m2) 2416 (22%) 12 (1%)
Obesity Class III (≥40 kg/m2) 1655 (15%) 24 (1%)
BMI classification for Japan and South Koreab
Respondents 3501 (100%) 418 (83%)
BMI <25 kg/m2 – 325 (78%)
Obesity Class 1 (25–29.9 kg/m2) 2696 (77%) 83 (20%)
Obesity Class 2 (30–34.9 kg/m2) 530 (15%) 9 (2%)
Obesity Class 3 (35–39.9 kg/m2) 134 (4%) 0
Obesity Class 4 (≥40 kg/m2) 141 (4%) 1 (<1%)
Number of comorbidities
0 3829 (26%)
1 3610 (25%)
2 2868 (20%)
3 2060 (14%)
≥4 2136 (15%)
HCP category
PCP 1415 (51%)
Specialist 1370 (49%)
Diabetologist/endocrinologist 488 (18%)
Cardiologist 301 (11%)
Internal medicine (non-PCP) 272 (10%)
Gastroenterologist 160 (6%)
Obstetrician/gynaecologist 133 (5%)
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each country for age, gender, household income, education and region
(Appendix S1, page 4). HCP data were not weighted.
3 | RESULTS
A total of 14 502 PwO and 2785 HCPs completed the survey (Table 1
and Figure S1) as per the target sample size for 11 participating coun-
tries. The mean response rate was 20% for PwO and 17% for HCPs;
the mean eligibility rate was 19% for PwO and 61% for HCPs; and the
mean completion time was 28 minutes for PwO and 35 minutes for
HCPs (Appendix S1, page 5).
A total of 68% of PwO and 88% of HCPs agreed with the state-
ment that obesity is a chronic disease (Figure S2A). Most PwO (82%)
and HCPs (76%) believed that obesity has a large impact on overall
health (Figure S2B). In comparison, 75%–85% of PwOs and 82%–93%
of HCPs stated that diabetes, stroke, cancer or chronic obstructive
pulmonary disease has a large impact on overall health. Despite recog-
nizing obesity as a disease that impacts overall health, most PwO
assumed full responsibility for weight loss (81%) and considered life-
style a key factor in their struggle with obesity (63%) (Figure 1; see
Figure S3 for complete data). Also, 30% of HCPs placed the responsi-
bility for weight loss on PwO, and 79% agreed that their patients
would need to completely change their lifestyle to lose weight. Only
31% of HCPs thought their patients were motivated to lose weight,
whereas 48% of PwO said they were motivated to lose weight
(Figure 1) and only 20% of PwO had no plans for weight loss within
the next 6 months (Figure S4). Most PwO and HCPs considered
unhealthy eating habits (62% of PwO; 89% of HCPs) and lack of exer-
cise (73% of PwO; 88% of HCPs) as barriers to weight loss, whereas
fewer than half considered the genetic factors underlying obesity
(33% of PwO; 44% of HCPs) to be a barrier (Figure S5).
A total of 81% of PwO stated that they had made at least one
serious weight loss effort in the past (Figure 2A). Conversely, on
average, HCPs reported that only 35% of their patients with obesity
had made a serious weight loss effort (Figure 2B). Of patients who
had made a serious weight loss attempt in the past year, the mean
proportion defined by HCPs as responding successfully was 30%
(Figure S6). A substantial proportion of PwO (62%) believed they
could lose weight if they set their mind to it (Figure 1). However,
many PwO struggled to lose weight and to maintain weight loss
(Figure 2C,D); only 37% of PwO reported weight loss of at least 5%
body mass over the past 3 years and, among those, only 29% were
able to maintain the weight loss for at least 1 year (11% of
PwO total).
Only approximately half of all PwO had discussed their weight
with an HCP in the past 5 years (Figure 3A). It took a median of 3 years
and a mean of 6 years between the reported time that PwO first
began struggling with excess weight or obesity and when they first
had a weight management conversation with an HCP (Figure 3B).
Moreover, 46% of the PwO who discussed weight with an HCP initi-
ated the conversation themselves (Figure S7A). In contrast, on aver-
age, HCPs reported discussing weight with 68% of their patients with
obesity, with the patient initiating the conversation only one third of
the time (Figure S7B). The main reason provided by HCPs for initiating
a weight management conversation was obesity-related complications
(Figure S8).
Among PwO who had discussed their weight with an HCP during
the past 5 years, 67% had been diagnosed with obesity in the past
(36% of PwO in total) (Figure 3A). On average, HCPs informed their
patients with obesity that they had a diagnosis of obesity 75% of the
time and 6% of HCPs never informed their patients of a diagnosis of
obesity (Figure S9). Only 39% of PwO who had discussed their weight
with an HCP were scheduled for a follow-up appointment (21% of
PwO in total) (Figure 3A); however, 94% of PwO reported attending
or planning to attend a follow-up appointment if scheduled
(Figure S10A). On average, HCPs scheduled follow-up appointments
with 44% of their patients to discuss obesity; 55% of HCPs reported
that patients kept these follow-up appointments always or most of
the time (Figure S10B).
TABLE 1 (Continued)
PwO (n = 14 502) HCPs (n = 2785)
Nutritionist (Italy only) 9 (<1%)
Bariatrics/obesity medicinec 5 (<1%)
Hepatologist (Australia only) 2 (<1%)
Obesity specialistd
Yes 1868 (67%)
No 917 (33%)
Data are median (range) or number (%) and are reported for the final unweighted sample.
Abbreviations: BMI, body mass index; HCP, healthcare professional; PwO, people wth obesity; PCP, primary care physician.
aClasses I (BMI 30–34.9 kg/m2), II (BMI 35–39.9 kg/m2) and III (BMI ≥40 kg/m2) apply to Australia, Chile, Israel, Italy, Mexico, Saudi Arabia, Spain, the UAE
and the UK.
bClasses 1 (BMI 25–29.9 kg/m2), 2 (BMI 30–34.9 kg/m2), 3 (BMI 35–39.9 kg/m2) and 4 (BMI ≥40 kg/m2) apply to Japan and South Korea.
cBariatric surgeons were ineligible per protocol pre-specified criteria.
dA physician who meets at least one of the following criteria: at least 50% of their patients are seen for obesity/weight management, or has
advanced/formal training in treatment of obesity/weight management beyond medical school, or considers themself to be an expert in obesity/weight loss
management, or works in an obesity service clinic.
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Among all PwO, 41% would set themselves an ambitious weight
loss target of 11%–20% (overall mean 16%) (Figure S11A). PwO
reported receiving similar recommended targets from HCPs (overall
mean 17%) (Figure S11B). The weight management goals most fre-
quently selected by PwO were to reduce the risks associated with
excess weight and to prevent a health condition (46%) and to improve
appearance (33%) (Figure S12).
The most frequent methods for managing weight discussed
between PwO and HCPs were general improvement in eating habits
and general increase in physical activity level, whereas specific diet or
exercise programmes, tracking, weight loss medications and bariatric
surgery were less likely to have been discussed (Figure S13A). Refer-
rals to specialists were recommended infrequently (Figure S13A).
General improvements in eating habits and physical activity were per-
ceived to be highly effective by most PwO and HCPs; however, more
PwO than HCPs perceived weight loss medications and bariatric sur-
gery to be effective (Figure S13B).
A total of 35% of PwO found that conversations with an HCP
concerning weight management were very or extremely helpful
(Figure S14); and 68% of PwO liked the fact that their HCP brought
up the subject of weight, or would like them to do so (Figure 3C).
Conversations with HCPs concerning weight management can be
quite motivating and positive for PwO, with 64% reporting positive
feelings after such a conversation (Figure 3D). Negative feelings after
a conversation concerning weight loss were reported by 44% of PwO.
However, only 3% of PwO reported feeling offended (Figure 3D).
The main reason provided by PwO for not discussing weight man-
agement with their HCP was a belief that it was their own responsibil-
ity to manage their weight (reported by 44% of PwO vs 9% of HCPs),
whereas the main reason provided by HCPs for not discussing obesity
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agreement with statement (top 2)
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80
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1b. My patients' weight loss is completely their responsibility
2a. For me to lose weight, I would need to completely change my lifestyle
2b. For my patients to lose weight, they would need to completely change their lifestyles
3a. I could lose weight if I really set my mind to it
3b. My patients could lose weight if they really set their mind to it
4a. I am motivated to lose weight
4b. My patients are motivated to lose weight
5a. I know how to lose weight
5b. My patients know what they need to do to lose weight
6a. I know how to keep the weight off
6b. My patients know how to keep the weight off
7a. I do not feel comfortable bringing up my weight unless my HCP mentions it first
7b. I do not feel comfortable bringing up my patients' weight unless they mention it first
8a. I am past the point where I can lose weight on my own
8b. My patients are past the point where they can lose weight on their own
9a. My HCP has a responsibility to actively contribute to a successful weight loss effort
9b. I have a responsibility to actively contribute to my patients' weight loss efforts
10a. If I lost weight, it would be easy for me to keep the weight off
10b. If my patients lost weight, it would be easy for them to keep the weight off
11a. Obesity is less important to me than other diseases
11b. Obesity is less important to me than many of the other diseases I treat
12a. There is nothing my doctor can do to help me manage my weight
12b. There is nothing I can do to help patients manage their weight
13a. It is easy for me to lose weight
13b. It is easy for my patients to lose weight
14a. I am happy with my current weight
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Attitudes towards obesity
F IGURE 1 PwO and HCP agreement with statements regarding attitudes towards obesity. Rated on a scale of 1–5. HCPs = green; PwO =
orange. Abbreviations: HCP, healthcare professional; PwO, people with obesity
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with a patient was their perception that the patient was not interested
in losing weight (reported by 71% of HCPs vs 7% of PwO) (Figure 4;
see Figure S15 for complete data). More than half of the HCPs sur-
veyed indicated that the limited appointment time is also a factor in
not discussing weight loss (Figure 4). Data concerning other outcomes
are presented in Figures S16–S19.
4 | DISCUSSION
The ACTION-IO study identified several key gaps in obesity care and
a misalignment between the perceptions and attitudes of PwO and
HCPs. Both PwO and HCPs stated that they recognized obesity as a
chronic disease; however, most PwO assumed complete responsibility
for weight loss. Furthermore, both PwO and HCPs put emphasis on
lifestyle-related factors rather than biological factors, including
genetic predisposition, as being significant barriers to weight loss. The
results suggest that many PwO are concerned about the impact of
excess weight on their health and are making serious efforts to lose
weight, but they have a limited response to such weight loss efforts
on their own. In contrast, the fact that HCPs believe that PwO are not
interested or motivated to lose weight may be preventing conversa-
tions concerning weight loss. This might reflect the actual experience
of HCPs or may represent an unconscious negative bias.
Obesity is recognized as a chronic disease by several national and
international organizations including the World Obesity Federation,1
the European Association for the Study of Obesity,11 The Obesity
Society,25 the American Medical Association26 and the UK Royal Col-
lege of Physicians.27 Obesity involves a genetic predisposition and
specific pathophysiological alterations, and it is not simply the result
of lifestyle.3,4 However, only 26% of PwO in this study believed that
their HCP has a responsibility to actively contribute to their weight
loss efforts. Other studies have previously highlighted a disconnection
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between perceptions and actions. In a study in Australia, 78% of PwO
agreed that their HCP had a role in their weight management, but only
58% would ask their HCP for advice concerning weight loss.28
Compared with the US ACTION study, a smaller proportion of
PwO in this international study had discussed their weight with an
HCP in the past 5 years (US ACTION, 71%; ACTION-IO, 54%); but
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weight. C, Proportion of PwO who like or would like their HCP to bring up weight during appointments. D, PwO feelings after discussing their
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among those, a greater proportion had received a diagnosis of obesity
(US ACTION, 55%; ACTION-IO, 67%).19 A similar proportion of PwO
in the USA and internationally thought weight loss was completely
their responsibility (US ACTION, 82%; ACTION-IO, 81%), and this
was the main reason that PwO did not initiate a weight management
conversation with an HCP in both studies.19 In the USA, HCPs cited
lack of time as a main reason for not initiating weight loss
conversations,19 whereas, internationally, HCPs cited limited patient
motivation or patient disinterest in losing weight as the main reasons,
in stark contrast to the responses of PwO, and reflecting a need for
education.
A potential barrier to effective obesity care that was identified here
was the length of time (years) between when PwO began struggling
with their weight and when they first had a weight management con-
versation with an HCP. Decreasing this time gap could reduce the com-
plications of obesity experienced by PwO and, ultimately, would lessen
the economic burden of the disease.6,7 Appropriate and supportive
weight management conversations should be initiated earlier as a pre-
ventive approach, before complications occur. Jointly agreeing that a
patient has overweight or obesity, with a BMI calculation in the context
of their personal health profile, may be an effective way to initiate such
a conversation.29 Discussing the genetic component and biological con-
tributors to obesity4,30 with the patient, using explanatory illustrations
that are tailored to the patient's knowledge base, where relevant, could
help to diminish self-blame and could encourage a continued dialogue
and receptiveness to support from the HCP. Recognizing positive
patient responses to conversational cues may allow for therapeutic
intervention or development of a management plan.9,15,31
Our data suggest that PwO are motivated to engage in weight loss
efforts and would like their HCPs to initiate a conversation about
weight. This is consistent with a UK study showing that most patients
found discussing their weight with an HCP appropriate and helpful.32
As obesity is a chronic disease, there is also a need to improve refer-
rals and follow-up appointments for management of obesity. Part of
this effort calls for eradication of the prevalent stigmatizing attitudes
that are highlighted in prior studies33 and for eradication of HCPs'
misperception that PwO are not motivated, as shown here.
The weight loss targets reported in this study were higher than
those achievable for most PwO with existing non-surgical interven-
tions, as demonstrated by the low proportion of PwO who achieved
and maintained a weight loss of at least 10%. Setting realistic and
achievable weight loss goals could contribute to management of
expectations, with collaborative communication and more manageable
targets potentially providing encouragement for continued patient
engagement. Guidelines suggest a weight loss goal of 5%–10%,
depending on the severity of obesity, over a period of 6 months.10
However, even a 3%–5% reduction in weight can provide clinically
meaningful health benefits.34 Opportunities for improving obesity
management include: improving education of PwO, HCPs, HCP stu-
dents, governments and the public in general concerning the biological
basis of obesity; challenging the misperception that obesity is under
an individual's control;33 obtaining unanimous recognition of obesity
as a chronic progressive disease; addressing HCPs' attitudes towards
PwO; promoting earlier initiation of helpful weight loss conversations;
improving education of HCPs and HCP students concerning clinical
management of obesity, including effective advice on diet and physi-
cal activity, as well as medical and surgical therapy, while emphasizing
the value of a multidisciplinary approach;9-15 and increasing the fre-
quency of diagnosis, follow-up appointments and referrals for effec-
tive evidence-based treatment. Obesity is an adiposity-based chronic
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disease, the complexity of which cannot be reflected by BMI alone,35
and this may contribute to the reluctance of HCPs to provide a diag-
nosis of obesity. However, as recommended by current clinical prac-
tice guidelines, BMI is used for the initial assessment and diagnosis of
obesity, taking into account factors such as age, ethnicity and
muscularity.9-15
Limitations of this study include the cross-sectional and descrip-
tive nature, reliance on self-reported height and weight, which could
underestimate BMI, and the accuracy of respondent recall. The fairly
low response rates are typical for survey-based research (Appendix
S1, page 5). Low response rates can affect sample representativeness
and are a known limitation of this type of study. Internet access could
also have restricted participation in some countries. Strengths of the
study include the large number of respondents, the international
nature of the study and the scientific rigor with which the survey was
designed and implemented, including stratified sampling to provide a
cohort representative of the general population.
Overall, our data suggest that PwO are motivated to lose weight and
that there is an opportunity for HCPs to initiate earlier, effective weight
loss conversations with minimal fear of offence. PwO may not recognize
the need to reduce excess weight until it has an impact on their health,
further supporting the requirement for HCPs to raise the topic of weight
before such obesity-related complications occur. Our study also reveals
a global need for improved education of both PwO and HCPs con-
cerning the biological basis and clinical management of obesity, and for a
more positive attitude on the part of HCPs towards initiating discussions
with PwO concerning weight and weight management.
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